Details
Category: Volume 07 Issue 05 May 2019
Hits: 1301

Title: HIV A Deadly Virus: Clinical Knowledge

Authors: Abhishek, Santosh Kumar, Aditya Narnoly, Jasbir Meher, Pragjyoti Baruah

 DOI: https://dx.doi.org/10.18535/jmscr/v7i5.139

Abstract

 

HIV is a deadly virus and the person living with HIV is growing in the world. In rural and backward area, the knowledge regarding HIV is still less and this disease decrease the life of a person. The reality of mode of spread of infection, the occurrence of infection, the exposure of infection in Dentist is more as compared to other Profession of Medical world. Dentist is still doing all types of work like extraction, filling, Denture making without knowing the facts and figures of HIV related Disease. The aim of this article is to deal with the clinical aspect of HIV related issue.

Keywords: HIV, Dentistry, AIDS.

References

  1. Patton LL. HIV disease. Dent Clin North Am 2003;47(3):467-92.
  2. https://en.wikipedia.org/wiki/Kimberly_Bergalis
  3. Rostamzadeh M, Afkhamzadeh A, Afrooz S, Mohamadi K, Rasouli MA. Dentists' knowledge, attitudes and practices regarding Hepatitis B and C and HIV/AIDS in Sanandaj, Iran. BMC Oral Health. 2018 Dec 18;18(1):220.
  4. Groenewegen H et al. Severe periodontitis is more common in HIV- infected patients. Journal of Infection , Volume 78 , Issue 3 , 171 – 177.
  5. Alshouibi EN, AlAlyani WS. Human immunodeficiency virus related discrimination in general dentistry. Saudi Med J. 2018;39(11):1148-1153.
  6. National AIDS Control Organization – HIV FACT AND FIGURE. Available from: http://naco.gov.in/hiv-facts-figures
  7. Medical Microbiology: An Introduction to infection Disease: Retroviruses, Human Immunodeficiency Virus, and acquired Immunodeficiency Syndrome. Available from: https://www.brainkart.com/article/Acquired-Immuno-Deficiency-Syndrome-(AIDS)--Clinical-Aspects_20622/
  8. Patton LL, Shugars DC. Immunologic and viral markers of HIV-1 disease progression: implications for dentistry. J Am Dent Assoc 1999;130(9):1313-22.
  9. Lam-Ubol A, Rungsiyanont S, Vacharotayangul P, Sappayatosok K, Chankanka O. Oral manifestations, salivary flow rates and Candida species in Thai HIV-infected patients. J Clin Exp Dent. 2019 Feb 1;11(2).
  10. Berberi A, Aoun G. Oral lesions associated with human immunodeficiency virus in 75 adult patients: a clinical study. J Korean Assoc Oral Maxillofac Surg. 2017 Dec;43(6)
  11. Modified from centers of disease control and prevention (CDC): Recommendation Reports: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescence and adults, MMWR, 41 (PR-17):1,1992.
  12. Little, J.W., Falace, D. A., Miller, C.S., & Rhodus, N.L. (2002), Dental management of the medically compromised patient, 6th ed. St. Louis, MO: Mosby.
  13. Revised from Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, Department of Health and Human Services (DHHS), 2001.
  14. Proceedings Workshop on Needle Exchange and Bleach Distribution Programs. National Research Council (US) and Institute of Medicine (US) Panel on Needle Exchange and Bleach Distribution Programs. Washington (DC): National Academies Press (US); 1994.
  15. Spire B., Barre-Sinoussi, F., Montagnier, L., et al. 1984. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet ii:899-901.
  16. McDougal, J.S., Cort, S.P., Kennedy, M.S., et al. 1985. Immunoassay for the Detection and Quantitation of Infectious Human Retrovirus, Lymphadenopathy Associated Virus (LAV), J Immun Meth 76:171-83.
  17. Martin, L.S., McDougal, J.S., Loskoski, S.L. 1985. Disinfection and Inactivation of the Human T Lymphadenopathy Virus Type III/Lymphadenopathy-Associated Virus J Infec Dis 152:400-3.
  18. Sattar, S.A., Springthorpe, V.S. 1991. Survival and Disinfectant Inactivation of the Human Immunodeficiency Virus: A Critical Review. Rev Infect Dis 13:430-47.
  19. Quinnan, G.V. Jr., Wells, M.A., Wittek, A.E., et al. 1986. Inactivation of Human T-cell Lymphotropic Virus, Type III by Heat, Chemicals, and Irradiation., Transfusion 26(5); 481-3.
  20. Hanson, P.J.V., Gor, D., Jeffries, D.J., et al. 1989. Chemical Inactivation of HIV on Surfaces. BMJ 298:862-4.
  21. Tjotaa, E., Hungnes, O., Grinde, B., 1991. Survival of HIV-1 Activity After Disinfection, Temperature and pH Changes, or Drying. J Med Vir 35:223-227.
  22. Resnick, L., Veren K., Salahuddin, S. Z., et al. 1986. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 255:53-68.
  23. Bloomfield, S.F., Smith-Burchnell, C.A., Dalgleish, A.G. 1990. Evaluation of Hypochlorite-Releasing Disinfectants Against the Human Immunodeficiency Virus (HIV), J Hosp Inf 15:273-8.
  24. Aranda-Anzaldo, A., Viza, D., Busnel, R.G. 1992. Chemical Inactivation of Human Immunodeficiency Virus in Vitro. J Viro Meth 37:71-82.
  25. Busnel, R.G., Aranda-Anzaldo, A., Viza, D., and Hutchinson, S. A. 1990. Parameters of HIV inactivation by disinfectants. Int Conf AIDS Abstract 1076.
  26. Van Bueren, J., Salman, H., Simpson, R.A., et al. 1992. Survival of HIV and Inactivation by Heat and Chemical Disinfectants. Int Conf AIDS, Jul 19-24; 8(2):A69.
  27. Prince, D.L., Prince, R.N., Prince, H.N. 1990. Inactivation of Human Immunodeficiency Virus Type 1 and Herpes Simplex Virus Type 2 by Commercial Hospital Disinfectants. Chem Times & Trends January: 13-17.

Corresponding Author

Dr Abhishek

Assistant Professor, Dentistry Department, Katihar Medical College & Hospital, Katihar, Bihar